Press Releases 2012

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V. (NYSE, Euronext: DSM KON) was recognized at the 2nd Annual Biopharma Asia Industry Awards in Singapore for their end-to-end suite of customer solutions, spearheading contract manufacturing innovations and raising standards in the region.

DSM Pharmaceutical Products, the custom manufacturing business of Royal DSM N.V. (NYSE, Euronext: DSM KON) and Agennix AG (Frankfurt Stock Exchange: AGX) have signed a new contract under which DSM will continue to manufacture talactoferrin for Agennix at commercial levels.

Royal DSM N.V., (DSM KON: NYSE/Euronext), today announced the signing of an agreement  with Indoco Remedies Limited, Mumbai, India, for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). The alliance came into effect in January 2012.